Impact Pharmaceutical Services

SEPTEMBER 15, 2023

Nonetheless, their rising popularity – eight of the top 10 best-selling drugs internationally in 2016 were biologics – underscores their increasing importance. Both processes are evolving to enhance product development and output. Biologics are more complex, though, with targeted mechanisms and potent pharmacological impacts.

Documentation 59

Documentation Process Improvement Compounding 59

ISPE

OCTOBER 27, 2022

Since 2016, drug approvals per clinical campaign have outpaced the average across all modalities, resulting in 11 FDA-approved therapies in that span. 5’-(E)-Vinylphosphonate: A Stable Phosphate Mimic Can Improve the RNAi Activity of siRNA-GalNAc Conjugates.” 11 (2 June 2016): 985–89. Brigham, et al. “5’-(E)-Vinylphosphonate:

Process Improvement 98

Process Improvement Packaging Dosage Compounding 98

ISPE

SEPTEMBER 11, 2023

12 April 2016. Pharmaceutical Processing World. BioProcess International 14 (2016):38–43. AI Technology There are multiple potential future applications of AI technology that can support more efficient technology transfer, scale-up, site monitoring, and regulatory submission processes (see Figure 2). October 2022.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

MARCH 15, 2023

linear) design process is central to successfully attaining such comprehensive sustainability goals and project needs (see Figure 1). 646 of 2016, 27 and the GHG Standard Scope 2. January 2016. 646 of 2016. Regulations 2016, Amendment, Energy Efficiency. 7 An integrative (vs. Recycling the Impossible.” August 2018.

Packaging 52

Packaging Labelling Health Compliance Process Improvement 52

ISPE

AUGUST 29, 2022

Following approval of an initial marketing application, postapproval changes are needed to ensure adequate supply, mitigate supply risk, expand patient market access, optimize manufacturing processes, improve analytical methods, and comply with new regulatory expectations. BioProcess International 14 (2016): 38–43. Smith, and R.

Documentation 52

Documentation FDA Communication Packaging 52

ISPE

SEPTEMBER 10, 2023

In addition to delaying optimization of manufacturing and controls, these types of long delays for approvals discourage continuous process improvements for approved products. On this basis, country approvals covering 2016–2020 were included in the analysis. 2 3 7 Pezzola, A., Globalization and Health 12, no.

Documentation 98

Documentation Process Improvement Packaging Pharmaceutical Companies 98